[Use of medications for the correction of functional disturbances in hemocoagulation and lipid peroxidation in patients with infectious myocarditis].
Disturbances were studied in the system of hemostasis, lipid peroxidation, functional condition of the cardiac muscle in patients with acute mild, moderately severe, and severe viral myocarditis. The studies were made before and after the treatment of patients with basal drug preparations, heparin, antioxidants (thiotriasaline, captopril). Therapeutic benefit from treatment with heparin, thiotriasaline was but insignificant in patients with mild, moderately severe, and severe course of the disease. It was only with the adoption of a complex therapy (basal drug preparations, heparin, thiotriasaline, captopril, diuretics) that patients derived clinical-and-laboratory-instrumental-and-social-and-economic benefit from treatment.
Doroshenko
B H
BH
D000975:Antioxidants / Q000627:therapeutic use; D001777:Blood Coagulation / Q000187:drug effects*; D004232:Diuretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D015227:Lipid Peroxidation / Q000187:drug effects*; D009205:Myocarditis / Q000097:blood / Q000188:drug therapy* / Q000821:virology; D009206:Myocardium / Q000378:metabolism; D011446:Prospective Studies; D014777:Virus Diseases / Q000097:blood / Q000188:drug therapy
D000975:Antioxidants; D004232:Diuretics; D006493:Heparin
Medykamentozna korektsiia funktsional'nykh porushen' hemokoaguliatsiï ta lipidnoï peroksydatsiï u khvorykh na infektsiĭnyĭ miokardyt.